RSS

Theranexus

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. Read more

News

Data on the involvement of the histaminergic system in the stimulating effect of a new drug candidate (THN 102) are being presented at the 11th Federation of European Neuroscience Societies (FENS) Forum by biopharma company, Theranexus. Read more

News

The first European approval for a Phase II clinical trial with THN102 in Parkinson’s patients has been announced by biopharmaceutical company, Theranexus. Read more

News